Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Digital repository of Slovenian research organisations
About
Search
Browse
Statistics
Contacts
Login
Show document
A+
|
A-
|
|
SLO
|
ENG
Title:
Znanost za prihodnost
Authors:
ID
Železnik, Peter
(Editor)
ID
Kraigher, Hojka
(Responsible editor)
ID
Humar, Miha
(Responsible editor)
Files:
PDF - Presentation file,
download
(3,33 MB)
MD5: 555F33ABC2BCD8AD7A5482FD33EAF417
PID:
20.500.12556/dirros/2d2f1c5e-9630-410f-8f2c-e992503c26e1
URL - Presentation file, visit
https://doi.org/10.20315/SFS.159
Language:
Slovenian
Organization:
SciVie - Slovenian Forestry Institute
Keywords:
gozdarstvo
,
divjad
,
varstvo gozdov
,
celulozna biomasa
,
gozdni proizvodi
,
Slovenija
,
zborniki
Publication status:
Published
PID:
20.500.12556/DiRROS-8361
UDC:
630(497.4)(082)
DOI:
10.20315/SFS.159
COBISS.SI-ID:
295004928
Note:
60 izv.;
Publication date in DiRROS:
12.06.2018
Views:
6768
Downloads:
1430
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
ŽELEZNIK, Peter (ed.), no date,
Znanost za prihodnost
[online]. [Accessed 3 April 2025]. Retrieved from: https://dirros.openscience.si/IzpisGradiva.php?lang=eng&id=8361
Copy citation
Share:
Similar works from our repository:
Analysis of the referral trend in ovarian cancer patients who need genetic assessment for treatment planning and presentation of new clinical pathways
Summary Guidelines for Treating Ovarian Cancer and Primary Peritoneal Serous Carcinoma
Rak jajčnikov in jajcevodov (Ca ovarii, Ca tubae): diagnostični algoritmi primarne bolezni
Our experience with bevacizumab in the primary treatment of epithelial ovarian cancer
Klinična pot genetske obravnave bolnic z epitelijskim nemucinoznim rakom jajčnikov/jajcevodov/primarnim peritonealnim seroznim karcinomom
Similar works from other repositories:
BRCA1/2 mutation testing from cytological samples in patients with ovarian, tubal and primary peritoneal serous cancer
AKR1B1 as a prognostic biomarker of high-grade serous ovarian cancer
BRCA1/2 STATUS AND CLINICO-PATHOLOGIC CHARACTERISTICS OF PATIENTS WITH DOUBLE PRIMARY BREAST AND OVARIAN CANCERAND OF PATIENTS WITH EPITHELIAL OVARIAN CANCER
AKR1C3 is associated with better survival of patients with endometrial carcinomas
Predictive value of the cancer stem cell related marker NANOG in ovarian serous carcinoma
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.
Licences
License:
CC BY-NC-ND 2.5 SI, Creative Commons Attribution-NonCommercial-NoDerivs 2.5 Slovenia
Link:
https://creativecommons.org/licenses/by-nc-nd/2.5/si/deed.en
Description:
You are free to reproduce and redistribute the material in any medium or format. You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you may not distribute the modified material. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Licensing start date:
12.06.2018
Collection
This document is a part of these collections:
Studia Forestalia Slovenica
Back